vs

Side-by-side financial comparison of BioAge Labs, Inc. (BIOA) and MOVING iMAGE TECHNOLOGIES INC. (MITQ). Click either name above to swap in a different company.

MOVING iMAGE TECHNOLOGIES INC. is the larger business by last-quarter revenue ($3.8M vs $3.1M, roughly 1.2× BioAge Labs, Inc.). MOVING iMAGE TECHNOLOGIES INC. runs the higher net margin — -10.2% vs -842.9%, a 832.6% gap on every dollar of revenue.

Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. Russian-born technology businessman Yuri Milner, along with investors including Jeff Bezos, funded the company in 2021, operations started in 2022.

Silicon Image Inc. was an American fabless semiconductor company based in Hillsboro, Oregon, and active from 1995 to 2015. The company designed circuits for mobile phones, consumer electronics and personal computers (PCs). It also manufactured wireless and wired connectivity products used for high-definition content. The company's semiconductor and IP products were deployed by manufacturers in devices such as smartphones, tablets, digital televisions (DTVs), and other consumer electronics, as...

BIOA vs MITQ — Head-to-Head

Bigger by revenue
MITQ
MITQ
1.2× larger
MITQ
$3.8M
$3.1M
BIOA
Higher net margin
MITQ
MITQ
832.6% more per $
MITQ
-10.2%
-842.9%
BIOA

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
BIOA
BIOA
MITQ
MITQ
Revenue
$3.1M
$3.8M
Net Profit
$-25.9M
$-388.0K
Gross Margin
30.7%
Operating Margin
-923.4%
-10.8%
Net Margin
-842.9%
-10.2%
Revenue YoY
10.2%
Net Profit YoY
26.4%
EPS (diluted)
$-0.72
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOA
BIOA
MITQ
MITQ
Q4 25
$3.1M
$3.8M
Q3 25
$2.1M
$5.6M
Q2 25
$2.4M
Q1 25
$1.5M
$3.6M
Q4 24
$3.4M
Q3 24
$0
$5.3M
Q2 24
$6.3M
Q1 24
$3.9M
Net Profit
BIOA
BIOA
MITQ
MITQ
Q4 25
$-25.9M
$-388.0K
Q3 25
$-20.2M
$509.0K
Q2 25
$-21.6M
Q1 25
$-12.9M
$-240.0K
Q4 24
$-527.0K
Q3 24
$-23.4M
$-25.0K
Q2 24
$-416.0K
Q1 24
$-601.0K
Gross Margin
BIOA
BIOA
MITQ
MITQ
Q4 25
30.7%
Q3 25
30.0%
Q2 25
Q1 25
29.8%
Q4 24
27.2%
Q3 24
26.1%
Q2 24
22.5%
Q1 24
17.4%
Operating Margin
BIOA
BIOA
MITQ
MITQ
Q4 25
-923.4%
-10.8%
Q3 25
-1126.6%
6.3%
Q2 25
-1027.0%
Q1 25
-1133.4%
-7.6%
Q4 24
-16.3%
Q3 24
-1.3%
Q2 24
-7.3%
Q1 24
-16.7%
Net Margin
BIOA
BIOA
MITQ
MITQ
Q4 25
-842.9%
-10.2%
Q3 25
-982.0%
9.1%
Q2 25
-894.0%
Q1 25
-891.0%
-6.7%
Q4 24
-15.3%
Q3 24
-0.5%
Q2 24
-6.6%
Q1 24
-15.4%
EPS (diluted)
BIOA
BIOA
MITQ
MITQ
Q4 25
$-0.72
$-0.04
Q3 25
$-0.56
$0.05
Q2 25
$-0.60
Q1 25
$-0.36
$-0.02
Q4 24
$-0.05
Q3 24
$-6.70
$0.00
Q2 24
$-0.04
Q1 24
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOA
BIOA
MITQ
MITQ
Cash + ST InvestmentsLiquidity on hand
$281.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$272.1M
$5.0M
Total Assets
$294.9M
$9.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOA
BIOA
MITQ
MITQ
Q4 25
$281.1M
Q3 25
$285.8M
Q2 25
$297.3M
Q1 25
$320.5M
Q4 24
Q3 24
$334.5M
Q2 24
Q1 24
Total Debt
BIOA
BIOA
MITQ
MITQ
Q4 25
Q3 25
Q2 25
Q1 25
$7.1M
Q4 24
Q3 24
$9.9M
Q2 24
Q1 24
Stockholders' Equity
BIOA
BIOA
MITQ
MITQ
Q4 25
$272.1M
$5.0M
Q3 25
$277.5M
$5.4M
Q2 25
$294.8M
Q1 25
$313.2M
$5.0M
Q4 24
$5.2M
Q3 24
$313.7M
$5.7M
Q2 24
$5.7M
Q1 24
$6.3M
Total Assets
BIOA
BIOA
MITQ
MITQ
Q4 25
$294.9M
$9.5M
Q3 25
$305.1M
$11.3M
Q2 25
$322.1M
Q1 25
$343.8M
$11.2M
Q4 24
$10.0M
Q3 24
$337.4M
$10.7M
Q2 24
$10.5M
Q1 24
$12.7M
Debt / Equity
BIOA
BIOA
MITQ
MITQ
Q4 25
Q3 25
Q2 25
Q1 25
0.02×
Q4 24
Q3 24
0.03×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOA
BIOA
MITQ
MITQ
Operating Cash FlowLast quarter
$-28.3M
$-1.6M
Free Cash FlowOCF − Capex
$-28.4M
FCF MarginFCF / Revenue
-921.5%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-82.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOA
BIOA
MITQ
MITQ
Q4 25
$-28.3M
$-1.6M
Q3 25
$-16.0M
$-167.0K
Q2 25
$-20.0M
Q1 25
$-17.4M
$53.0K
Q4 24
$70.0K
Q3 24
$-32.0K
Q2 24
$-472.0K
Q1 24
$1.0M
Free Cash Flow
BIOA
BIOA
MITQ
MITQ
Q4 25
$-28.4M
Q3 25
$-16.1M
Q2 25
$-20.1M
Q1 25
$-17.8M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
BIOA
BIOA
MITQ
MITQ
Q4 25
-921.5%
Q3 25
-782.2%
Q2 25
-834.5%
Q1 25
-1226.0%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
BIOA
BIOA
MITQ
MITQ
Q4 25
3.6%
Q3 25
1.1%
Q2 25
6.6%
Q1 25
29.4%
Q4 24
Q3 24
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
BIOA
BIOA
MITQ
MITQ
Q4 25
Q3 25
-0.33×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons